SlideShare a Scribd company logo
1 of 56
By Fikru.T
6/24/2023
Fikru.T
1
Microbial Diseases of the Respiratory System
Bacterial Diseases of the Upper Respiratory
System
6/24/2023
Fikru.T
2
Streptococcal Respiratory Diseases
Properties
 Gram positive in reaction
 Cocci arranged in pairs or chains during growth
 Contain normal flora & pathogenic Spp.
 Facultatively anaerobic
Cont.…
6/24/2023
Fikru.T
3
Classification of Streptococci
Based on:
1. Hemolytic rxns on blood agar
 Beta haemolytic streptococci; Complete disruption of erythrocytes with clearing of
the blood around the bacterial colonies on BA is called β hemolysis. e.g. S. pyogenes, S.
agalactiae
 Alpha haemolytic streptococci: partial/Incomplete lysis of erythrocytes s called α
hemolysis.
e.g. S. pneumoniae
 Non-haemolytic or gamma streptococci: Other streptococci are non-hemolytic
(sometimes called gamma hemolysis). e.g. Enterococci
2. Serologic specificity (Lancefield groups A–H)
3. Battery of Biochemical Tests:
Group A beta -Hemolytic Streptococci (Streptococcus
pyogens)
6/24/2023
Fikru.T
4
 Is the major cause of bacterial pharyngitis and scarlet and rheumatic fevers.
 The bacterium shows beta hemolysis after 24 hours on blood agar.
 have a number of structures, enzymes, and toxins that enable them to
survive as pathogens in the body. These include the following:
 M protein: causes inhibition of complement component C3b, thereby
interfering with opsonization
 The hyaluronic acid capsule may “camouflage” the bacterium from
phagocytes.
 Streptokinase's are enzymes that break down blood clots, presumably
enabling group A streptococci to spread rapidly through damaged tissues.
Cont..
6/24/2023
Fikru.T
5
 C5a peptidase is an enzyme that breaks down complement protein C5a. With this
enzyme, S. pyogenes decreases the movement of leukocytes into the site of infection.
 Pyrogenic (also called erythrogenic) toxins : stimulate leukocytes to release
cytokines that in turn stimulate fever, rash, and shock.
 Streptolysins: lyse erythrocytes, leukocytes, and platelets
Pathogenesis
 People spread S. pyogenes via respiratory droplets.
 Streptococci cause a variety of illnesses depending on the virulence factors.
 S. pyogenes frequently infects the pharynx, but the resulting disease is usually temporary, lasting
only until adaptive immune responses against bacterial antigens (particularly M protein and
streptolysins) clear the pathogen, usually within a week.
 Typically, strep throat and streptococcal bronchitis occur only when:-
o Normal competing microbiota are missing
Signs and Symptoms
6/24/2023
Fikru.T
6
 Streptococcal pharyngitis
 Laryngitis and bronchitis
 Scarlet fever
 Complications of some cases of untreated streptococcal pharyngitis
are acute glomerulonephritis and rheumatic fever
Cont..
6/24/2023
Fikru.T
7
Epidemiology
 Most cases of streptococcal pharyngitis occur during the winter and spring
among elementary and middle school children, probably because of
crowded conditions.
 One person can spread sufficient bacteria to cause disease by coughing
or sneezing.
Laboratory identification
Specimens for laboratory analysis can be obtained from throat swabs,
sputum, and blood.
 S. pyogenes forms characteristic small colonies surrounded by a
large zone of beta hemolysis on sheep blood agar.
 This organism is highly sensitive to bacitracin.
 Immunological tests
Treatment, and Prevention
6/24/2023
Fikru.T
8
 Penicillin is very effective against S. pyogenes
 Antibodies against M protein provide long-term protection against S.
pyogenes.
Corynebacterium diphtheriae
6/24/2023
Fikru.T
9
 Pathogen and Virulence Factors
 Is non-endospore-forming, Gram-positive bacteria.
 C. diphtheriae is non-capsulate, non-motile, "club-shaped“
bacteria.
 Facultative anaerobe
 Arranged in angular fashion like Chinese lettering arrangement
 Colonizing the skin and the respiratory, gastrointestinal, urinary and
genital tracts.
 Virulent C. diphtheriae contains a diphtheria toxin.
 The toxin gene is directly responsible for the signs and symptoms of
diphtheria.
Pathogenesis and Epidemiology
6/24/2023
Fikru.T
10
 C. diphtheriae is transmitted from person to person via respiratory droplets or
skin contact.
 Infections with C. diphtheriae have different effects depending on a host’s
immune status and the site of infection.
 Infections in immune individuals are asymptomatic
 In immunocompromised individuals most severe, resulting in the sudden and
rapid signs and symptoms of diphtheria and cause of childhood death.
Signs and symptoms
6/24/2023
Fikru.T
11
 Sore throat
 Localized pain
 Fever
Diagnosis, Treatment, and Prevention
6/24/2023
Fikru.T
12
Lab. Diagnosis:
Specimens:
 Include throat, and, or nasopharyngeal swabs to confirm a
diagnosis of throat diphtheria, and a skin swab if cutaneous
diphtheria is suspected
Microscopy:
 C. diphtheriae is gram positive bacteria appear in cluster like
Chinese letters
Culture
 C. diphtheriae is facultative anaerobe at optimum temperature of
35–37 ºC.
Treatment
6/24/2023
Fikru.T
13
o Early administration of antitoxin formed by the organisms at their site of entry and
multiplication
o The most important aspect of treatment is the administration of antitoxin
(immunoglobulins against the toxin) to neutralize diphtheria toxin.
o Antimicrobial drugs (Penicillin or Erythromycin)
o Penicillin or erythromycin kills Corynebacterium, preventing the synthesis of more
toxin
Bacterial Diseases of the Lower Respiratory
System
6/24/2023
Fikru.T
14
Pneumococcal Pneumonia: caused by Streptococcus also called
pneumococcal pneumonia—is the most common type of bacterial pneumonia,
accounting for most cases of community-acquired pneumonia (CAP).
Pathogen and Virulence Factors
Streptococcus Pneumoniae (Pneumococcus)
 S. pneumoniae are gram-positive, nonmotile, encapsulated cocci.
 In sputum pneumococci are typically arranged in pairs (diplococci); each
coccus is somewhat elongated and pointed at one end but rounded at the
other (lancet-shaped).
 S. pneumoniae is the most common cause of pneumonia and otitis
media and an important cause of meningitis and bacteremia
Cont..
6/24/2023
Fikru.T
15
 Pathogenesis and Epidemiology
 Pathogenic pneumococci secrete an attachment molecule
 Protein that mediates binding of the bacterium to epithelial cells of the
pharynx.
 Pneumococci are inhaled occasionally from the pharynx into the lung and
damaged either by a previous viral disease, such as influenza or measles,
or by other conditions, such as alcoholism, congestive heart failure, or
diabetes mellitus.
 Virulent serotypes also have polysaccharide capsules that protect them
from lysis by phagocytes and pneumococci that live in and eventually kill
Cont…
6/24/2023
Fikru.T
16
 As the bacteria multiply in the alveoli, they damage the lining of the alveoli,
allowing erythrocytes, leukocytes, and blood plasma to enter the lung.
 This fluid fills the alveoli, reducing the lung’s ability to transfer oxygen to the
blood and causing the pneumonia.
 It occurs most frequently in fall and winter in children or groups whose immune
responses are not fully active
Signs and Symptoms Pneumococcal pneumonia
6/24/2023
Fikru.T
17
 Fever
 Chills
 Congestion
 Cough
 Chest pain,
 Short, rapid breathing, and possibly nausea and vomiting.
Laboratory diagnosis
6/24/2023
Fikru.T
18
 Specimens for laboratory evaluation can be obtained from a
nasopharyngeal swab, blood, pus, sputum, or spinal fluid.
 α-Hemolytic colonies appear on blood agar
 Lancet-shaped, gram-positive diplococci are observed on a Gram stain of
the sample.
 Growth of these bacteria is inhibited by low concentrations of the
optochin, and the cells are lysed by bile acids (bile solubility positive).
Treatment
6/24/2023
Fikru.T
19
 Penicillin has long been the drug of choice against S. pneumoniae,
though about a third of pneumococcal isolates are now penicillin
resistant.
 Cephalosporin, erythromycin, clindamycin, vancomycin, or
fluoroquinolones are effective alternative treatments.
Mycoplasmal Pneumonia
6/24/2023
Fikru.T
20
 Mycoplasmal pneumonia is the leading type of pneumonia in children and
young adults, caused by Mycoplasma pneumoniae.
 Pathogen and Virulence Factors
 Mycoplasma pneumoniae is strictly aerobic and encapsulated.
 Lack of cell walls, allowing them to have a variety of shapes.
 Further, mycoplasmas have lipids in their cytoplasmic membranes called
sterols, a feature lacking in other prokaryotes.
 Microbes that can grow and reproduce independently of other cells.
 Their diameters range from 0.1 μm to 0.8 μm.
 Originally, scientists thought mycoplasmas were viruses because their
small size and flexibility enable them to squeeze through the pores of
filters that were then commonly used to remove bacteria from solutions;
however, mycoplasmas contain both RNA and DNA, and they divide by
binary fission—traits that viruses lack.
Pathogenesis
6/24/2023
Fikru.T
21
 Attachment of M. pneumoniae to the base of cilia (p1,p30,p116)
 Causes the cilia to stop action, and colonization eventually kills the
epithelial cells.
 This interrupts the normal removal of mucus from the respiratory tract by
the ciliary escalator, allowing colonization by other bacteria and causing a
buildup of mucus that irritates the respiratory tract.
Signs and Symptoms
6/24/2023
Fikru.T
22
 Fever, malaise, headache, sore throat, and excessive sweating, are not typical
of other types of pneumonia; thus is called primary atypical pneumonia.
 Primary atypical pneumonia may last for several weeks, but it is usually not
severe enough to require hospitalization or to cause death.
 Because symptoms can be mild, the disease is also sometimes called walking
pneumonia
Epidemiology
6/24/2023
Fikru.T
23
 Nasal secretions spread M. pneumoniae among people in close contacts,
such as classmates, family members, and dormitory residents.
 It is the most common form of pneumonia seen in high school and college
students.
 Primary atypical pneumonia occurs throughout the year.
.
Laboratory diagnosis
6/24/2023
Fikru.T
24
 Diagnosis of primary atypical pneumonia is difficult because mycoplasmas
are small and difficult to detect in clinical specimens or tissue samples.
 Further, mycoplasmas grow slowly in culture, requiring two to six weeks
before colonies are visible.
 Colonies of M. pneumoniae have a grainy appearance when the bacteria
grow on solid surfaces.
 Complement fixation, hemagglutination, and immunofluorescent tests
confirm a diagnosis, but such tests are nonspecific.
Treatment and prevention
6/24/2023
Fikru.T
25
Treatment
 Erythromycin
 Prevention
 Prevention is difficult because patients are often infected for long periods without signs or
symptoms.
 Nevertheless, frequent handwashing and avoidance of contact with contaminated fomites can
limit the spread of the pathogen.
 No vaccine against M. pneumonia is available.
Klebsiella pneumoniae
6/24/2023
Fikru.T
26
 Is an opportunistic pathogen that infects the respiratory systems of
humans and animals following inhalation.
 It is a nonmotile, Gram-negative rod that produces a prominent capsule
giving Klebsiella colonies a mucoid appearance and protecting the
bacterium from phagocytosis.
 K. pneumoniae may also be involved in meningitis, wound infections,
and urinary tract infections.
 Pathogenesis
 K. pneumoniae kills alveolar cells and often invades the blood, resulting in
bacteremia.
 They release endotoxin, which can trigger shock and disseminated
intravascular coagulation, leading to death.
Signs and Symptoms
6/24/2023
Fikru.T
27
 Besides the common signs and symptoms of bacterial pneumonia—
coughing, fever, and chest pain
 Often involves destruction of alveoli, resulting in the production of
thick, bloody sputum.
 Mortality rates are higher than with pneumococcal or Mycoplasmal
pneumonias
Epidemiology
6/24/2023
Fikru.T
28
 Alcoholics and other patients with compromised immunity such
as the elderly, people with AIDS, and very young children are at
greater risk of Klebsiella pneumonia.
Laboratory diagnosis
6/24/2023
Fikru.T
29
 Specimen: Sputum
 Smear: Gram-negative rods
 Culture: Large, mucoid, lactose-fermenting colonies on
MacConkey agar.
 Treatment
 Cephalosporin, and quinolones
 Prevention
 No vaccine is available.
 Prevention involves good aseptic technique by health care workers.
Genus Bordetella
6/24/2023
Fikru.T
30
 Strictly aerobic, non-spore forming, non motile ,gram negative coccobacilli
that appears singly or in pairs ,Catalase +ve
 Fastidious organism (require blood supplemented medium)
 Bordetella species include
o B. pertussis, B. parapertussis, B. bronchoseptica,
Cont.…
6/24/2023
Fikru.T
31
 Bordetella pertussis is medically importance species
 Bordetella pertussis, a highly communicable and important pathogen of
humans, causes whooping cough (pertussis).
 Bordetella parapertussis :can cause a similar disease.
 Bordetella bronchiseptica: causes diseases in animals, and only
occasionally causes respiratory disease and bacteremia in humans,
primarily in immunocompromised hosts.
Bordetella pertussis
6/24/2023
Fikru.T
32
 Virulence Factors
 Various adhesins and toxins mediate the disease.
 Two adhesins are filamentous hemagglutinin and pertussis toxin.
 Four toxins are:
 Pertussis toxin: interferes with ciliated epithelial cells’ metabolism,
resulting in increased mucus production. (Note that pertussis toxin is both
an adhesin and a toxin.)
 Adenylate cyclase toxin: which triggers increased mucus production and
inhibits leukocyte movement, phagocytosis, and killing
 Dermonecrotic toxin: which causes localized constriction and
hemorrhage of blood vessels, resulting in cell death and tissue destruction
 Tracheal cytotoxin: which at low concentrations inhibits the movement of
cilia on respiratory cells.
Pathogenesis
6/24/2023
Fikru.T
33
 Via its adhesins, B. pertussis binds to cilia in the trachea and interferes with
their action
 Filamentous hemagglutinin also binds to the cytoplasmic membranes of
neutrophils, initiating endocytosis of the bacterium.
 B. pertussis survives within the phagocytes, evading the immune system.
 Pertussis toxin causes infected cells to produce more receptors for
filamentous hemagglutinin, leading to further bacterial attachment.
Pertussis progresses through three phases
Cont.…
6/24/2023
Fikru.T
34
 After an incubation period of about 2 weeks, the "catarrhal stage"
develops, with mild coughing and sneezing.
 During this stage, large numbers of organisms are sprayed in droplets, and
the patient is highly infectious but not very ill.
 During the "paroxysmal" stage, the cough develops its explosive
character
 This leads to rapid exhaustion and may be associated with vomiting
Cont.…
6/24/2023
Fikru.T
35
 The "whoop" and major complications occur predominantly in infants.
 Major complications like encephalitis.
 The white blood count is high (16–30 x103/µL), with an absolute lymphocytosis.
 After 3-4 weeks the disease enters
Convalescent stage
 Frequency and severity of the coughing gradually decrease
 But secondary complications can occur
Lab diagnosis
6/24/2023
Fikru.T
36
Specimens:
 A saline nasal wash is the preferred specimen.
Culture
 For the isolation of B. pertussis must be cultured as soon as possible
after collecting the sample.
 A selective and enriched medium such as charcoal cephalexin
blood agar is recommended for the primary isolation of B. pertussis.
 Small, smooth, and convex colonies
Cont..
6/24/2023
Fikru.T
37
Treatment
 Sensitive to Erythromycin, tetracycline, chloramphenicol
Prevention and control
 adequate immunization of all infants (DTP)
Mycobacterium tuberculosis
6/24/2023
Fikru.T
38
 General characteristics
 Long, slender rods that are non motile
 Strictly aerobic & non – sporulated
 Cell walls contain unique class of very long-chain fatty acids (mycolic
acids).
Cont.…
6/24/2023
Fikru.T
39
 Cell walls contain mycolic acid, which is responsible for the unique
characteristics of this pathogen, including:
 Slow growth
 Protection from lysis when cells are phagocytized
 Resistance to Gram staining, detergents, and many common
antimicrobial drugs, but not to heat or ultraviolet irradiation
Virulence Factors
6/24/2023
Fikru.T
40
 M.TB does not possess the classic bacterial virulence factors such as
toxins, capsules, and fimbriae.
 However, a number of structural and physiological properties of the
bacterium are contributed to bacterial virulence and the pathology of
tuberculosis
The cell wall of M.TB is thick consisting of
Mycolic fatty acid 60% (long chain fatty acids) impermissive
to different substances
Epidemiology
6/24/2023
Fikru.T
41
• The principal mode of transmission is person-to-person transmission by
inhalation of the aerosol or air-borne droplet that contains M.tb bacilli
 A total of 1.6 million people died from TB in 2021 (including 187 000 people
with HIV). Worldwide.
 TB is the 13th leading cause of death and the second leading infectious killer
after COVID-19 (above HIV and AIDS).
Progression of active tuberculosis infection
6/24/2023
Fikru.T
42
A. Primary tuberculosis: occurs in a person who had no previous contact
with the organism.
1. Mycobacterium typically infects the respiratory tract via inhalation of respiratory
droplets from infected individuals.
2. Macrophages in alveoli phagocytize mycobacteria but are unable to digest them, in
part because the bacterium inhibits the fusion of lysosomes to endocytic vesicles.
3. Bacteria replicate freely within macrophages, gradually killing the phagocytes.
Bacteria released from dead macrophages are phagocytized by other macrophages
and beginning the new cycle
B. Disseminated tuberculosis
6/24/2023
Fikru.T
43
Results when macrophages carry the pathogen via blood and lymph
nodes to other sites, including bone marrow, spleen, kidneys, spinal
cord, and brain, leading to the destruction of tissue and clinical illness; for
example,
 tuberculous osteomyelitis, or
 tuberculous meningitis
6/24/2023
Fikru.T
44
C. Reactivation(secondary) of tuberculosis:
Reactivation is apparently caused by an impairment in immune status,
often associated with malnutrition, alcoholism, advanced age, or severe
stress.
Immunosuppressive medication or diseases such as diabetes and,
particularly, AIDS, are common preconditions.
Clinical Presentation
6/24/2023
Fikru.T
45
• Weight loss
• Productive cough (For more than 15 days)
• Chest pain
• High fever
• Night sweating
• Blood stained sputum
• M.tuberclosis primarily cause pulmonary disease but it can affect any
organ of the body.
Laboratory identification:
6/24/2023
Fikru.T
46
Specimens: Sputum, CSF, Biopsy
1. Microscopic examination
Ziehl Neelson staining / AFS
 Specific
 Rapid
 Cheap
Once the Mycobacteria is stained with primary stain it can
not be decolorized with acid, so-named as acid-fast
bacteria.
Procedure
6/24/2023
Fikru.T
47
1. Specked, purulent sputum for smear preparation (do not use
saliva)
2. Heat fix the dried smear,
 Since M. tuberculosis can infect almost any organ in the body, the
laboratory could receive a variety of extrapulmonary specimens.
E.g. body fluid, tissue, pus, CSF, urine, etc.
3. Cover the smear with carbon-fuchsin stain
Cont.…
6/24/2023
Fikru.T
48
4. Wash off the stain with clean water
5. Cover the smear with 3% acid alcohol for 5 minutes or until the
smear is sufficiently decolorized. i.e. pale pink.
6. Wash well with clean water
7. Cover the smear with methylene blue for 1 – 2 minutes.
Cont…
6/24/2023
Fikru.T
49
8. Wash off the stain with clean water.
9. Wipe the back of the slide clean, and place it in a draining
rack for the smear to air dry.
10. Examine the smear microscopically, using the 100x oil
immersion object.
Results
6/24/2023
Fikru.T
50
• AFB............. Red, straight or slightly curved rods,
occurring single or in a small groups
• Cells......................................... Blue
• Background Material ……….. Blue
REPORTING OF SPUTUM SMEAR
6/24/2023
Fikru.T
51
• When any definite red bacilli are seen report the smear as AFB positive
and give an indication of the number of bacteria present as follows:
1- 9 AFB /100 fields -------------- Report the exact number
10 – 100 AFB/100 fields ------------------ report +
1 – 10 AFB/field --------------------------- report ++
More than 10 AFB/field ------------------ report +++
 When no AFB are seen after examining 300 fields report the smear as ‘
No AFB are seen’ do not report as “Negative” because organisms may
be present but not seen in those fields examined.
2. Mycobacterial culture
6/24/2023
Fikru.T
52
There are three formulations
a. Broth media: E.g. Middlebrook 7 H9 & 7H12
• Support growth of small inocula/enrichment media
• Growth is more rapid than solid media
B. Semi - solid agar media
6/24/2023
Fikru.T
53
Include Middle brook 7H10 & 7H11 media
The media are used for:
Observing colony morphology (3-8 weeks)
Susceptibility testing
Selective media
C. Lowenstein - Jensen egg based media
6/24/2023
Fikru.T
54
 Contain defined glycerol, and complex organic substances (eg, fresh eggs or
egg yolks, potato flour, and other ingredients in various combinations).
 Malachite green is included to inhibit other bacteria.
 Is a solid media used as a selective media with added antibiotics.
 Requires about 3 - 8 weeks for growth to occur
3. Molecular Techniques
6/24/2023
Fikru.T
55
• Real-Time PCR: Gene amplification (quantification)
• Sensitivity: 80 - 85%, specificity ~ 99%
6/24/2023
Fikru T.
56

More Related Content

Similar to Bacterial and Mycoplasmal Diseases of the Respiratory System

Similar to Bacterial and Mycoplasmal Diseases of the Respiratory System (20)

Infectious Diseases 12
Infectious Diseases  12Infectious Diseases  12
Infectious Diseases 12
 
RHEUMATIC HEART DISEASE BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE S...
RHEUMATIC HEART DISEASE BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE S...RHEUMATIC HEART DISEASE BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE S...
RHEUMATIC HEART DISEASE BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE S...
 
Bacteriology.pptx
Bacteriology.pptxBacteriology.pptx
Bacteriology.pptx
 
Pathophysiology tubercuslosis
Pathophysiology tubercuslosisPathophysiology tubercuslosis
Pathophysiology tubercuslosis
 
COMP. MENINGITIS.ppt
COMP. MENINGITIS.pptCOMP. MENINGITIS.ppt
COMP. MENINGITIS.ppt
 
Infectious disease p2
Infectious disease p2Infectious disease p2
Infectious disease p2
 
Systemic_MycosesM
Systemic_MycosesMSystemic_MycosesM
Systemic_MycosesM
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Genus streptococcus
Genus streptococcusGenus streptococcus
Genus streptococcus
 
Orthomyxoviridae (2)
Orthomyxoviridae (2)Orthomyxoviridae (2)
Orthomyxoviridae (2)
 
03 URTI.pptx
03 URTI.pptx03 URTI.pptx
03 URTI.pptx
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
small Mouse diseases
small Mouse diseasessmall Mouse diseases
small Mouse diseases
 
TUBERCULOSIS pharmacology notes types cure
TUBERCULOSIS pharmacology notes types cureTUBERCULOSIS pharmacology notes types cure
TUBERCULOSIS pharmacology notes types cure
 
Pneumocystis jirovecii infection
Pneumocystis jirovecii infectionPneumocystis jirovecii infection
Pneumocystis jirovecii infection
 
Bacteriology1 strept-phse ii-12-10-2010 -
Bacteriology1 strept-phse ii-12-10-2010 -Bacteriology1 strept-phse ii-12-10-2010 -
Bacteriology1 strept-phse ii-12-10-2010 -
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
Infectious Dz Lecture #1
Infectious Dz Lecture #1Infectious Dz Lecture #1
Infectious Dz Lecture #1
 

More from TofikMohammed3

404414_INTESTINAL AND LUMINAL PROTOZOA.ppt
404414_INTESTINAL AND LUMINAL PROTOZOA.ppt404414_INTESTINAL AND LUMINAL PROTOZOA.ppt
404414_INTESTINAL AND LUMINAL PROTOZOA.pptTofikMohammed3
 
Urinary System Histology note_25_615.pdf
Urinary System Histology note_25_615.pdfUrinary System Histology note_25_615.pdf
Urinary System Histology note_25_615.pdfTofikMohammed3
 
L3. Posterior Abdmaaasddddden last ).pdf
L3. Posterior Abdmaaasddddden last ).pdfL3. Posterior Abdmaaasddddden last ).pdf
L3. Posterior Abdmaaasddddden last ).pdfTofikMohammed3
 
fdocuments.net_agents-that-affect-bone-mineral-homeostasis-paul.ppt
fdocuments.net_agents-that-affect-bone-mineral-homeostasis-paul.pptfdocuments.net_agents-that-affect-bone-mineral-homeostasis-paul.ppt
fdocuments.net_agents-that-affect-bone-mineral-homeostasis-paul.pptTofikMohammed3
 
COMMON DISEASES OF THE SKIN.pptx
COMMON DISEASES OF THE SKIN.pptxCOMMON DISEASES OF THE SKIN.pptx
COMMON DISEASES OF THE SKIN.pptxTofikMohammed3
 
باثوهObstructiveLungDiseaseI-1.pptx
باثوهObstructiveLungDiseaseI-1.pptxباثوهObstructiveLungDiseaseI-1.pptx
باثوهObstructiveLungDiseaseI-1.pptxTofikMohammed3
 
embryo respiratory4.pdf
embryo respiratory4.pdfembryo respiratory4.pdf
embryo respiratory4.pdfTofikMohammed3
 
Clininical Anatomy UL.pptx
Clininical Anatomy UL.pptxClininical Anatomy UL.pptx
Clininical Anatomy UL.pptxTofikMohammed3
 
5_2019_02_14!09_06_35_AM.ppt
5_2019_02_14!09_06_35_AM.ppt5_2019_02_14!09_06_35_AM.ppt
5_2019_02_14!09_06_35_AM.pptTofikMohammed3
 
development of musculoskeletal system.ppt
development of musculoskeletal system.pptdevelopment of musculoskeletal system.ppt
development of musculoskeletal system.pptTofikMohammed3
 
Vessels of the lower limb.ppt
Vessels of the lower limb.pptVessels of the lower limb.ppt
Vessels of the lower limb.pptTofikMohammed3
 
Nerves of the lower limb.ppt
Nerves of the lower limb.pptNerves of the lower limb.ppt
Nerves of the lower limb.pptTofikMohammed3
 
Code of Medical Ethics in Ethiopia.pptx
Code of Medical Ethics in Ethiopia.pptxCode of Medical Ethics in Ethiopia.pptx
Code of Medical Ethics in Ethiopia.pptxTofikMohammed3
 
ANSCholinergicDrugs2010.ppt
ANSCholinergicDrugs2010.pptANSCholinergicDrugs2010.ppt
ANSCholinergicDrugs2010.pptTofikMohammed3
 
AUTONOMIC_NERVOUS_SYSTEM_AND_DRUGS-final.pptx
AUTONOMIC_NERVOUS_SYSTEM_AND_DRUGS-final.pptxAUTONOMIC_NERVOUS_SYSTEM_AND_DRUGS-final.pptx
AUTONOMIC_NERVOUS_SYSTEM_AND_DRUGS-final.pptxTofikMohammed3
 

More from TofikMohammed3 (20)

404414_INTESTINAL AND LUMINAL PROTOZOA.ppt
404414_INTESTINAL AND LUMINAL PROTOZOA.ppt404414_INTESTINAL AND LUMINAL PROTOZOA.ppt
404414_INTESTINAL AND LUMINAL PROTOZOA.ppt
 
Urinary System Histology note_25_615.pdf
Urinary System Histology note_25_615.pdfUrinary System Histology note_25_615.pdf
Urinary System Histology note_25_615.pdf
 
L3. Posterior Abdmaaasddddden last ).pdf
L3. Posterior Abdmaaasddddden last ).pdfL3. Posterior Abdmaaasddddden last ).pdf
L3. Posterior Abdmaaasddddden last ).pdf
 
fdocuments.net_agents-that-affect-bone-mineral-homeostasis-paul.ppt
fdocuments.net_agents-that-affect-bone-mineral-homeostasis-paul.pptfdocuments.net_agents-that-affect-bone-mineral-homeostasis-paul.ppt
fdocuments.net_agents-that-affect-bone-mineral-homeostasis-paul.ppt
 
COMMON DISEASES OF THE SKIN.pptx
COMMON DISEASES OF THE SKIN.pptxCOMMON DISEASES OF THE SKIN.pptx
COMMON DISEASES OF THE SKIN.pptx
 
باثوهObstructiveLungDiseaseI-1.pptx
باثوهObstructiveLungDiseaseI-1.pptxباثوهObstructiveLungDiseaseI-1.pptx
باثوهObstructiveLungDiseaseI-1.pptx
 
6. SHOCK 31.pptx
6. SHOCK 31.pptx6. SHOCK 31.pptx
6. SHOCK 31.pptx
 
embryo respiratory4.pdf
embryo respiratory4.pdfembryo respiratory4.pdf
embryo respiratory4.pdf
 
1. Introduction1.pptx
1. Introduction1.pptx1. Introduction1.pptx
1. Introduction1.pptx
 
Clininical Anatomy UL.pptx
Clininical Anatomy UL.pptxClininical Anatomy UL.pptx
Clininical Anatomy UL.pptx
 
attachment-1.pptx
attachment-1.pptxattachment-1.pptx
attachment-1.pptx
 
5_2019_02_14!09_06_35_AM.ppt
5_2019_02_14!09_06_35_AM.ppt5_2019_02_14!09_06_35_AM.ppt
5_2019_02_14!09_06_35_AM.ppt
 
musculoskeletal.pptx
musculoskeletal.pptxmusculoskeletal.pptx
musculoskeletal.pptx
 
development of musculoskeletal system.ppt
development of musculoskeletal system.pptdevelopment of musculoskeletal system.ppt
development of musculoskeletal system.ppt
 
Vessels of the lower limb.ppt
Vessels of the lower limb.pptVessels of the lower limb.ppt
Vessels of the lower limb.ppt
 
Nerves of the lower limb.ppt
Nerves of the lower limb.pptNerves of the lower limb.ppt
Nerves of the lower limb.ppt
 
Code of Medical Ethics in Ethiopia.pptx
Code of Medical Ethics in Ethiopia.pptxCode of Medical Ethics in Ethiopia.pptx
Code of Medical Ethics in Ethiopia.pptx
 
Medical Ethics.pptx
Medical Ethics.pptxMedical Ethics.pptx
Medical Ethics.pptx
 
ANSCholinergicDrugs2010.ppt
ANSCholinergicDrugs2010.pptANSCholinergicDrugs2010.ppt
ANSCholinergicDrugs2010.ppt
 
AUTONOMIC_NERVOUS_SYSTEM_AND_DRUGS-final.pptx
AUTONOMIC_NERVOUS_SYSTEM_AND_DRUGS-final.pptxAUTONOMIC_NERVOUS_SYSTEM_AND_DRUGS-final.pptx
AUTONOMIC_NERVOUS_SYSTEM_AND_DRUGS-final.pptx
 

Recently uploaded

Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoybabeytanya
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalorenarwatsonia7
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Miss joya
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls ServiceMiss joya
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...narwatsonia7
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls ServiceMiss joya
 
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoybabeytanya
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Servicemakika9823
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...Taniya Sharma
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Deliverynehamumbai
 
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...narwatsonia7
 
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...Call girls in Ahmedabad High profile
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...Taniya Sharma
 

Recently uploaded (20)

Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Panvel Mumbai📲 9833363713 💞 Full Night Enjoy
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
 
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...Bangalore Call Girls Hebbal Kempapura Number 7001035870  Meetin With Bangalor...
Bangalore Call Girls Hebbal Kempapura Number 7001035870 Meetin With Bangalor...
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
 
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night EnjoyCall Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
Call Girl Number in Vashi Mumbai📲 9833363713 💞 Full Night Enjoy
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
 
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
Russian Call Girls in Bangalore Manisha 7001305949 Independent Escort Service...
 
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 

Bacterial and Mycoplasmal Diseases of the Respiratory System

  • 2. Bacterial Diseases of the Upper Respiratory System 6/24/2023 Fikru.T 2 Streptococcal Respiratory Diseases Properties  Gram positive in reaction  Cocci arranged in pairs or chains during growth  Contain normal flora & pathogenic Spp.  Facultatively anaerobic
  • 3. Cont.… 6/24/2023 Fikru.T 3 Classification of Streptococci Based on: 1. Hemolytic rxns on blood agar  Beta haemolytic streptococci; Complete disruption of erythrocytes with clearing of the blood around the bacterial colonies on BA is called β hemolysis. e.g. S. pyogenes, S. agalactiae  Alpha haemolytic streptococci: partial/Incomplete lysis of erythrocytes s called α hemolysis. e.g. S. pneumoniae  Non-haemolytic or gamma streptococci: Other streptococci are non-hemolytic (sometimes called gamma hemolysis). e.g. Enterococci 2. Serologic specificity (Lancefield groups A–H) 3. Battery of Biochemical Tests:
  • 4. Group A beta -Hemolytic Streptococci (Streptococcus pyogens) 6/24/2023 Fikru.T 4  Is the major cause of bacterial pharyngitis and scarlet and rheumatic fevers.  The bacterium shows beta hemolysis after 24 hours on blood agar.  have a number of structures, enzymes, and toxins that enable them to survive as pathogens in the body. These include the following:  M protein: causes inhibition of complement component C3b, thereby interfering with opsonization  The hyaluronic acid capsule may “camouflage” the bacterium from phagocytes.  Streptokinase's are enzymes that break down blood clots, presumably enabling group A streptococci to spread rapidly through damaged tissues.
  • 5. Cont.. 6/24/2023 Fikru.T 5  C5a peptidase is an enzyme that breaks down complement protein C5a. With this enzyme, S. pyogenes decreases the movement of leukocytes into the site of infection.  Pyrogenic (also called erythrogenic) toxins : stimulate leukocytes to release cytokines that in turn stimulate fever, rash, and shock.  Streptolysins: lyse erythrocytes, leukocytes, and platelets Pathogenesis  People spread S. pyogenes via respiratory droplets.  Streptococci cause a variety of illnesses depending on the virulence factors.  S. pyogenes frequently infects the pharynx, but the resulting disease is usually temporary, lasting only until adaptive immune responses against bacterial antigens (particularly M protein and streptolysins) clear the pathogen, usually within a week.  Typically, strep throat and streptococcal bronchitis occur only when:- o Normal competing microbiota are missing
  • 6. Signs and Symptoms 6/24/2023 Fikru.T 6  Streptococcal pharyngitis  Laryngitis and bronchitis  Scarlet fever  Complications of some cases of untreated streptococcal pharyngitis are acute glomerulonephritis and rheumatic fever
  • 7. Cont.. 6/24/2023 Fikru.T 7 Epidemiology  Most cases of streptococcal pharyngitis occur during the winter and spring among elementary and middle school children, probably because of crowded conditions.  One person can spread sufficient bacteria to cause disease by coughing or sneezing. Laboratory identification Specimens for laboratory analysis can be obtained from throat swabs, sputum, and blood.  S. pyogenes forms characteristic small colonies surrounded by a large zone of beta hemolysis on sheep blood agar.  This organism is highly sensitive to bacitracin.  Immunological tests
  • 8. Treatment, and Prevention 6/24/2023 Fikru.T 8  Penicillin is very effective against S. pyogenes  Antibodies against M protein provide long-term protection against S. pyogenes.
  • 9. Corynebacterium diphtheriae 6/24/2023 Fikru.T 9  Pathogen and Virulence Factors  Is non-endospore-forming, Gram-positive bacteria.  C. diphtheriae is non-capsulate, non-motile, "club-shaped“ bacteria.  Facultative anaerobe  Arranged in angular fashion like Chinese lettering arrangement  Colonizing the skin and the respiratory, gastrointestinal, urinary and genital tracts.  Virulent C. diphtheriae contains a diphtheria toxin.  The toxin gene is directly responsible for the signs and symptoms of diphtheria.
  • 10. Pathogenesis and Epidemiology 6/24/2023 Fikru.T 10  C. diphtheriae is transmitted from person to person via respiratory droplets or skin contact.  Infections with C. diphtheriae have different effects depending on a host’s immune status and the site of infection.  Infections in immune individuals are asymptomatic  In immunocompromised individuals most severe, resulting in the sudden and rapid signs and symptoms of diphtheria and cause of childhood death.
  • 11. Signs and symptoms 6/24/2023 Fikru.T 11  Sore throat  Localized pain  Fever
  • 12. Diagnosis, Treatment, and Prevention 6/24/2023 Fikru.T 12 Lab. Diagnosis: Specimens:  Include throat, and, or nasopharyngeal swabs to confirm a diagnosis of throat diphtheria, and a skin swab if cutaneous diphtheria is suspected Microscopy:  C. diphtheriae is gram positive bacteria appear in cluster like Chinese letters Culture  C. diphtheriae is facultative anaerobe at optimum temperature of 35–37 ºC.
  • 13. Treatment 6/24/2023 Fikru.T 13 o Early administration of antitoxin formed by the organisms at their site of entry and multiplication o The most important aspect of treatment is the administration of antitoxin (immunoglobulins against the toxin) to neutralize diphtheria toxin. o Antimicrobial drugs (Penicillin or Erythromycin) o Penicillin or erythromycin kills Corynebacterium, preventing the synthesis of more toxin
  • 14. Bacterial Diseases of the Lower Respiratory System 6/24/2023 Fikru.T 14 Pneumococcal Pneumonia: caused by Streptococcus also called pneumococcal pneumonia—is the most common type of bacterial pneumonia, accounting for most cases of community-acquired pneumonia (CAP). Pathogen and Virulence Factors Streptococcus Pneumoniae (Pneumococcus)  S. pneumoniae are gram-positive, nonmotile, encapsulated cocci.  In sputum pneumococci are typically arranged in pairs (diplococci); each coccus is somewhat elongated and pointed at one end but rounded at the other (lancet-shaped).  S. pneumoniae is the most common cause of pneumonia and otitis media and an important cause of meningitis and bacteremia
  • 15. Cont.. 6/24/2023 Fikru.T 15  Pathogenesis and Epidemiology  Pathogenic pneumococci secrete an attachment molecule  Protein that mediates binding of the bacterium to epithelial cells of the pharynx.  Pneumococci are inhaled occasionally from the pharynx into the lung and damaged either by a previous viral disease, such as influenza or measles, or by other conditions, such as alcoholism, congestive heart failure, or diabetes mellitus.  Virulent serotypes also have polysaccharide capsules that protect them from lysis by phagocytes and pneumococci that live in and eventually kill
  • 16. Cont… 6/24/2023 Fikru.T 16  As the bacteria multiply in the alveoli, they damage the lining of the alveoli, allowing erythrocytes, leukocytes, and blood plasma to enter the lung.  This fluid fills the alveoli, reducing the lung’s ability to transfer oxygen to the blood and causing the pneumonia.  It occurs most frequently in fall and winter in children or groups whose immune responses are not fully active
  • 17. Signs and Symptoms Pneumococcal pneumonia 6/24/2023 Fikru.T 17  Fever  Chills  Congestion  Cough  Chest pain,  Short, rapid breathing, and possibly nausea and vomiting.
  • 18. Laboratory diagnosis 6/24/2023 Fikru.T 18  Specimens for laboratory evaluation can be obtained from a nasopharyngeal swab, blood, pus, sputum, or spinal fluid.  α-Hemolytic colonies appear on blood agar  Lancet-shaped, gram-positive diplococci are observed on a Gram stain of the sample.  Growth of these bacteria is inhibited by low concentrations of the optochin, and the cells are lysed by bile acids (bile solubility positive).
  • 19. Treatment 6/24/2023 Fikru.T 19  Penicillin has long been the drug of choice against S. pneumoniae, though about a third of pneumococcal isolates are now penicillin resistant.  Cephalosporin, erythromycin, clindamycin, vancomycin, or fluoroquinolones are effective alternative treatments.
  • 20. Mycoplasmal Pneumonia 6/24/2023 Fikru.T 20  Mycoplasmal pneumonia is the leading type of pneumonia in children and young adults, caused by Mycoplasma pneumoniae.  Pathogen and Virulence Factors  Mycoplasma pneumoniae is strictly aerobic and encapsulated.  Lack of cell walls, allowing them to have a variety of shapes.  Further, mycoplasmas have lipids in their cytoplasmic membranes called sterols, a feature lacking in other prokaryotes.  Microbes that can grow and reproduce independently of other cells.  Their diameters range from 0.1 μm to 0.8 μm.  Originally, scientists thought mycoplasmas were viruses because their small size and flexibility enable them to squeeze through the pores of filters that were then commonly used to remove bacteria from solutions; however, mycoplasmas contain both RNA and DNA, and they divide by binary fission—traits that viruses lack.
  • 21. Pathogenesis 6/24/2023 Fikru.T 21  Attachment of M. pneumoniae to the base of cilia (p1,p30,p116)  Causes the cilia to stop action, and colonization eventually kills the epithelial cells.  This interrupts the normal removal of mucus from the respiratory tract by the ciliary escalator, allowing colonization by other bacteria and causing a buildup of mucus that irritates the respiratory tract.
  • 22. Signs and Symptoms 6/24/2023 Fikru.T 22  Fever, malaise, headache, sore throat, and excessive sweating, are not typical of other types of pneumonia; thus is called primary atypical pneumonia.  Primary atypical pneumonia may last for several weeks, but it is usually not severe enough to require hospitalization or to cause death.  Because symptoms can be mild, the disease is also sometimes called walking pneumonia
  • 23. Epidemiology 6/24/2023 Fikru.T 23  Nasal secretions spread M. pneumoniae among people in close contacts, such as classmates, family members, and dormitory residents.  It is the most common form of pneumonia seen in high school and college students.  Primary atypical pneumonia occurs throughout the year. .
  • 24. Laboratory diagnosis 6/24/2023 Fikru.T 24  Diagnosis of primary atypical pneumonia is difficult because mycoplasmas are small and difficult to detect in clinical specimens or tissue samples.  Further, mycoplasmas grow slowly in culture, requiring two to six weeks before colonies are visible.  Colonies of M. pneumoniae have a grainy appearance when the bacteria grow on solid surfaces.  Complement fixation, hemagglutination, and immunofluorescent tests confirm a diagnosis, but such tests are nonspecific.
  • 25. Treatment and prevention 6/24/2023 Fikru.T 25 Treatment  Erythromycin  Prevention  Prevention is difficult because patients are often infected for long periods without signs or symptoms.  Nevertheless, frequent handwashing and avoidance of contact with contaminated fomites can limit the spread of the pathogen.  No vaccine against M. pneumonia is available.
  • 26. Klebsiella pneumoniae 6/24/2023 Fikru.T 26  Is an opportunistic pathogen that infects the respiratory systems of humans and animals following inhalation.  It is a nonmotile, Gram-negative rod that produces a prominent capsule giving Klebsiella colonies a mucoid appearance and protecting the bacterium from phagocytosis.  K. pneumoniae may also be involved in meningitis, wound infections, and urinary tract infections.  Pathogenesis  K. pneumoniae kills alveolar cells and often invades the blood, resulting in bacteremia.  They release endotoxin, which can trigger shock and disseminated intravascular coagulation, leading to death.
  • 27. Signs and Symptoms 6/24/2023 Fikru.T 27  Besides the common signs and symptoms of bacterial pneumonia— coughing, fever, and chest pain  Often involves destruction of alveoli, resulting in the production of thick, bloody sputum.  Mortality rates are higher than with pneumococcal or Mycoplasmal pneumonias
  • 28. Epidemiology 6/24/2023 Fikru.T 28  Alcoholics and other patients with compromised immunity such as the elderly, people with AIDS, and very young children are at greater risk of Klebsiella pneumonia.
  • 29. Laboratory diagnosis 6/24/2023 Fikru.T 29  Specimen: Sputum  Smear: Gram-negative rods  Culture: Large, mucoid, lactose-fermenting colonies on MacConkey agar.  Treatment  Cephalosporin, and quinolones  Prevention  No vaccine is available.  Prevention involves good aseptic technique by health care workers.
  • 30. Genus Bordetella 6/24/2023 Fikru.T 30  Strictly aerobic, non-spore forming, non motile ,gram negative coccobacilli that appears singly or in pairs ,Catalase +ve  Fastidious organism (require blood supplemented medium)  Bordetella species include o B. pertussis, B. parapertussis, B. bronchoseptica,
  • 31. Cont.… 6/24/2023 Fikru.T 31  Bordetella pertussis is medically importance species  Bordetella pertussis, a highly communicable and important pathogen of humans, causes whooping cough (pertussis).  Bordetella parapertussis :can cause a similar disease.  Bordetella bronchiseptica: causes diseases in animals, and only occasionally causes respiratory disease and bacteremia in humans, primarily in immunocompromised hosts.
  • 32. Bordetella pertussis 6/24/2023 Fikru.T 32  Virulence Factors  Various adhesins and toxins mediate the disease.  Two adhesins are filamentous hemagglutinin and pertussis toxin.  Four toxins are:  Pertussis toxin: interferes with ciliated epithelial cells’ metabolism, resulting in increased mucus production. (Note that pertussis toxin is both an adhesin and a toxin.)  Adenylate cyclase toxin: which triggers increased mucus production and inhibits leukocyte movement, phagocytosis, and killing  Dermonecrotic toxin: which causes localized constriction and hemorrhage of blood vessels, resulting in cell death and tissue destruction  Tracheal cytotoxin: which at low concentrations inhibits the movement of cilia on respiratory cells.
  • 33. Pathogenesis 6/24/2023 Fikru.T 33  Via its adhesins, B. pertussis binds to cilia in the trachea and interferes with their action  Filamentous hemagglutinin also binds to the cytoplasmic membranes of neutrophils, initiating endocytosis of the bacterium.  B. pertussis survives within the phagocytes, evading the immune system.  Pertussis toxin causes infected cells to produce more receptors for filamentous hemagglutinin, leading to further bacterial attachment. Pertussis progresses through three phases
  • 34. Cont.… 6/24/2023 Fikru.T 34  After an incubation period of about 2 weeks, the "catarrhal stage" develops, with mild coughing and sneezing.  During this stage, large numbers of organisms are sprayed in droplets, and the patient is highly infectious but not very ill.  During the "paroxysmal" stage, the cough develops its explosive character  This leads to rapid exhaustion and may be associated with vomiting
  • 35. Cont.… 6/24/2023 Fikru.T 35  The "whoop" and major complications occur predominantly in infants.  Major complications like encephalitis.  The white blood count is high (16–30 x103/µL), with an absolute lymphocytosis.  After 3-4 weeks the disease enters Convalescent stage  Frequency and severity of the coughing gradually decrease  But secondary complications can occur
  • 36. Lab diagnosis 6/24/2023 Fikru.T 36 Specimens:  A saline nasal wash is the preferred specimen. Culture  For the isolation of B. pertussis must be cultured as soon as possible after collecting the sample.  A selective and enriched medium such as charcoal cephalexin blood agar is recommended for the primary isolation of B. pertussis.  Small, smooth, and convex colonies
  • 37. Cont.. 6/24/2023 Fikru.T 37 Treatment  Sensitive to Erythromycin, tetracycline, chloramphenicol Prevention and control  adequate immunization of all infants (DTP)
  • 38. Mycobacterium tuberculosis 6/24/2023 Fikru.T 38  General characteristics  Long, slender rods that are non motile  Strictly aerobic & non – sporulated  Cell walls contain unique class of very long-chain fatty acids (mycolic acids).
  • 39. Cont.… 6/24/2023 Fikru.T 39  Cell walls contain mycolic acid, which is responsible for the unique characteristics of this pathogen, including:  Slow growth  Protection from lysis when cells are phagocytized  Resistance to Gram staining, detergents, and many common antimicrobial drugs, but not to heat or ultraviolet irradiation
  • 40. Virulence Factors 6/24/2023 Fikru.T 40  M.TB does not possess the classic bacterial virulence factors such as toxins, capsules, and fimbriae.  However, a number of structural and physiological properties of the bacterium are contributed to bacterial virulence and the pathology of tuberculosis The cell wall of M.TB is thick consisting of Mycolic fatty acid 60% (long chain fatty acids) impermissive to different substances
  • 41. Epidemiology 6/24/2023 Fikru.T 41 • The principal mode of transmission is person-to-person transmission by inhalation of the aerosol or air-borne droplet that contains M.tb bacilli  A total of 1.6 million people died from TB in 2021 (including 187 000 people with HIV). Worldwide.  TB is the 13th leading cause of death and the second leading infectious killer after COVID-19 (above HIV and AIDS).
  • 42. Progression of active tuberculosis infection 6/24/2023 Fikru.T 42 A. Primary tuberculosis: occurs in a person who had no previous contact with the organism. 1. Mycobacterium typically infects the respiratory tract via inhalation of respiratory droplets from infected individuals. 2. Macrophages in alveoli phagocytize mycobacteria but are unable to digest them, in part because the bacterium inhibits the fusion of lysosomes to endocytic vesicles. 3. Bacteria replicate freely within macrophages, gradually killing the phagocytes. Bacteria released from dead macrophages are phagocytized by other macrophages and beginning the new cycle
  • 43. B. Disseminated tuberculosis 6/24/2023 Fikru.T 43 Results when macrophages carry the pathogen via blood and lymph nodes to other sites, including bone marrow, spleen, kidneys, spinal cord, and brain, leading to the destruction of tissue and clinical illness; for example,  tuberculous osteomyelitis, or  tuberculous meningitis
  • 44. 6/24/2023 Fikru.T 44 C. Reactivation(secondary) of tuberculosis: Reactivation is apparently caused by an impairment in immune status, often associated with malnutrition, alcoholism, advanced age, or severe stress. Immunosuppressive medication or diseases such as diabetes and, particularly, AIDS, are common preconditions.
  • 45. Clinical Presentation 6/24/2023 Fikru.T 45 • Weight loss • Productive cough (For more than 15 days) • Chest pain • High fever • Night sweating • Blood stained sputum • M.tuberclosis primarily cause pulmonary disease but it can affect any organ of the body.
  • 46. Laboratory identification: 6/24/2023 Fikru.T 46 Specimens: Sputum, CSF, Biopsy 1. Microscopic examination Ziehl Neelson staining / AFS  Specific  Rapid  Cheap Once the Mycobacteria is stained with primary stain it can not be decolorized with acid, so-named as acid-fast bacteria.
  • 47. Procedure 6/24/2023 Fikru.T 47 1. Specked, purulent sputum for smear preparation (do not use saliva) 2. Heat fix the dried smear,  Since M. tuberculosis can infect almost any organ in the body, the laboratory could receive a variety of extrapulmonary specimens. E.g. body fluid, tissue, pus, CSF, urine, etc. 3. Cover the smear with carbon-fuchsin stain
  • 48. Cont.… 6/24/2023 Fikru.T 48 4. Wash off the stain with clean water 5. Cover the smear with 3% acid alcohol for 5 minutes or until the smear is sufficiently decolorized. i.e. pale pink. 6. Wash well with clean water 7. Cover the smear with methylene blue for 1 – 2 minutes.
  • 49. Cont… 6/24/2023 Fikru.T 49 8. Wash off the stain with clean water. 9. Wipe the back of the slide clean, and place it in a draining rack for the smear to air dry. 10. Examine the smear microscopically, using the 100x oil immersion object.
  • 50. Results 6/24/2023 Fikru.T 50 • AFB............. Red, straight or slightly curved rods, occurring single or in a small groups • Cells......................................... Blue • Background Material ……….. Blue
  • 51. REPORTING OF SPUTUM SMEAR 6/24/2023 Fikru.T 51 • When any definite red bacilli are seen report the smear as AFB positive and give an indication of the number of bacteria present as follows: 1- 9 AFB /100 fields -------------- Report the exact number 10 – 100 AFB/100 fields ------------------ report + 1 – 10 AFB/field --------------------------- report ++ More than 10 AFB/field ------------------ report +++  When no AFB are seen after examining 300 fields report the smear as ‘ No AFB are seen’ do not report as “Negative” because organisms may be present but not seen in those fields examined.
  • 52. 2. Mycobacterial culture 6/24/2023 Fikru.T 52 There are three formulations a. Broth media: E.g. Middlebrook 7 H9 & 7H12 • Support growth of small inocula/enrichment media • Growth is more rapid than solid media
  • 53. B. Semi - solid agar media 6/24/2023 Fikru.T 53 Include Middle brook 7H10 & 7H11 media The media are used for: Observing colony morphology (3-8 weeks) Susceptibility testing Selective media
  • 54. C. Lowenstein - Jensen egg based media 6/24/2023 Fikru.T 54  Contain defined glycerol, and complex organic substances (eg, fresh eggs or egg yolks, potato flour, and other ingredients in various combinations).  Malachite green is included to inhibit other bacteria.  Is a solid media used as a selective media with added antibiotics.  Requires about 3 - 8 weeks for growth to occur
  • 55. 3. Molecular Techniques 6/24/2023 Fikru.T 55 • Real-Time PCR: Gene amplification (quantification) • Sensitivity: 80 - 85%, specificity ~ 99%